News
Stay up to date on NKGen Biotech’s company news and announcements.
Stay up to date on NKGen Biotech’s company news and announcements.
Check back soon for upcoming events!
Follow NKGen on social media to keep up-to-date on the latest company news and the science of Natural Killer cells!
NKGen Biotech, Inc.
Corporate Headquarters
3001 Daimler Street
Santa Ana, CA 92705
Irvine Office
19800 MacArthur Blvd., Suite 900
Irvine, CA 92612
NKGen Biotech Announces FDA Clearance of Investigational New Drug (IND) Application for SNK01 NK Cell Therapy in Parkinson’s Disease
NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit
NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
NKGen Biotech Announces Upcoming Presentation on SNK01 NK Cell Therapy in Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
NKGen Biotech Presents Additional Phase 1 Clinical Trial Data in Alzheimer’s Disease at the Tau2024 Global Conference
NKGen Biotech Announces Upcoming Presentation on SNK01 in Alzheimer’s Disease at the Tau2024 Global Conference